{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:09:04Z","timestamp":1767499744193,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.leukres.2009.08.003","type":"journal-article","created":{"date-parts":[[2009,8,30]],"date-time":"2009-08-30T04:09:23Z","timestamp":1251605363000},"page":"e5-e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia"],"prefix":"10.1016","volume":"34","author":[{"given":"Stefania","family":"Mariani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Tornaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Sassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Basciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Gambacorti-Passerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Spera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Gnessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.08.003_bib1","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.003_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1096\/fj.06-6910com","article-title":"Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning","volume":"21","author":"H\u00e4gerkvist","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.leukres.2009.08.003_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/db08-0080","article-title":"Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db\/db mice","volume":"58","author":"Han","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.leukres.2009.08.003_bib4","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1073\/pnas.0810246105","article-title":"Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Louvet","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2009.08.003_bib5","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1200\/JCO.2004.04.217","article-title":"Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment","volume":"22","author":"Breccia","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2009.08.003_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM200503103521023","article-title":"Imatinib and regression of type 2 diabetes","volume":"352","author":"Veneri","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl. ECR21","key":"10.1016\/j.leukres.2009.08.003_bib7","article-title":"Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib","volume":"90","author":"Breccia","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2009.08.003_bib8","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/dc06-0984","article-title":"Paraneoplastic insulin resistance syndrome in advanced aggressive fibromatosis (desmoid tumor) treated by imatinib mesylate","volume":"29","author":"Folli","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.leukres.2009.08.003_bib9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF03347451","article-title":"Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor","volume":"30","author":"Haap","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.leukres.2009.08.003_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4158\/EP.13.2.126","article-title":"Imatinib and type 2 diabetes","volume":"13","author":"Dingli","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/j.leukres.2009.08.003_bib11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/ndt\/gfm052","article-title":"Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation","volume":"22","author":"Thierry","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.leukres.2009.08.003_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2337\/dc06-1696","article-title":"High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes","volume":"30","author":"Buzzetti","year":"2007","journal-title":"Diabetes Care"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609003919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609003919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:56:37Z","timestamp":1758934597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609003919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0145212609003919"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.08.003","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2009.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}